BMP-7 administration reduced renal fibrosis, provided neuroprotection in ischemic stroke injury and Parkinson’s disease, and promoted bone regeneration, with no reported off-target toxicity [56,57,58,59]. The gene discussed is BMP7; the disease is renal fibrosis.